Literature DB >> 8816504

Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity.

R A Klinghoffer1, B Duckworth, M Valius, L Cantley, A Kazlauskas.   

Abstract

Upon binding of platelet-derived growth factor (PDGF), the PDGF beta receptor (PDGFR) undergoes autophosphorylation on distinct tyrosine residues and binds several SH2-domain-containing signal relay enzymes, including phosphatidylinositol 3-kinase (PI3K), phospholipase C gamma (PLC gamma), the GTPase-activating protein of Ras (RasGAP), and the tyrosine phosphatase SHP-2. In this study, we have investigated whether PDGF-dependent PI3K activation is affected by the other proteins that associate with the PDGFR. We constructed and characterized a series of PDGFR mutants which contain binding sites for PI3K as well as one additional protein, either RasGAP, SHP-2, or PLC gamma. While all of the receptors had wild-type levels of PDGF-stimulated tyrosine kinase activity and associated with comparable amounts of PI3K activity, their abilities to trigger accumulation of PI3K products in vivo differed dramatically. The wild-type receptor, as well as receptors that recruited PI3K or PI3K and SHP-2, were all capable of fully activating PI3K. In contrast, receptors that associated with PI3K and RasGAP or PI3K and PLC gamma displayed a greatly reduced ability to stimulate production of PI3K products. When this series of receptors was tested for their ability to activate Ras, we observed a strong positive correlation between Ras activation and PI3K activation. Further investigation of the relationship between Ras and PI3K indicated that Ras was upstream of PI3K. Thus, activation of PI3K requires not only binding of PI3K to the tyrosine-phosphorylated PDGFR but accumulation of GTP-bound Ras as well. Furthermore, PLC gamma and RasGAP negatively modulate PDGF-dependent PI3K activation. Finally, PDGF-stimulated signal relay can be regulated by altering the ratio of SH2-domain-containing enzymes that are recruited to the PDGFR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816504      PMCID: PMC231592          DOI: 10.1128/MCB.16.10.5905

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  The phosphotyrosine phosphatase PTP1D, but not PTP1C, is an essential mediator of fibroblast proliferation induced by tyrosine kinase and G protein-coupled receptors.

Authors:  N Rivard; F R McKenzie; J M Brondello; J Pouysségur
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

2.  Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase.

Authors:  J Wang; K R Auger; L Jarvis; Y Shi; T M Roberts
Journal:  J Biol Chem       Date:  1995-05-26       Impact factor: 5.157

3.  Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor.

Authors:  R Yao; G M Cooper
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

4.  Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase.

Authors:  Q Hu; A Klippel; A J Muslin; W J Fantl; L T Williams
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

5.  The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors.

Authors:  S Roche; M Koegl; S A Courtneidge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Signal transduction. The hunt for Ras targets.

Authors:  L A Feig; B Schaffhausen
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

7.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

8.  Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit.

Authors:  T Rordorf-Nikolic; D J Van Horn; D Chen; M F White; J M Backer
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

Review 9.  Phosphatidylinositol 3-kinase.

Authors:  R Kapeller; L C Cantley
Journal:  Bioessays       Date:  1994-08       Impact factor: 4.345

10.  Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation.

Authors:  A K Arvidsson; E Rupp; E Nånberg; J Downward; L Rönnstrand; S Wennström; J Schlessinger; C H Heldin; L Claesson-Welsh
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

View more
  37 in total

1.  Src family kinases are required for integrin but not PDGFR signal transduction.

Authors:  R A Klinghoffer; C Sachsenmaier; J A Cooper; P Soriano
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

2.  Quantitative model of Ras-phosphoinositide 3-kinase signalling cross-talk based on co-operative molecular assembly.

Authors:  Harjeet Kaur; Chang Shin Park; Jodee M Lewis; Jason M Haugh
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 3.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

4.  RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology.

Authors:  Hetian Lei; Cynthia X Qian; Jinghu Lei; Luis J Haddock; Shizuo Mukai; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2015-03-02       Impact factor: 4.272

5.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway.

Authors:  A Khwaja; P Rodriguez-Viciana; S Wennström; P H Warne; J Downward
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

6.  v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras.

Authors:  Tsuyoshi Akagi; Kazutaka Murata; Tomoyuki Shishido; Hidesaburo Hanafusa
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

7.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

Review 8.  Regulation and modulation of PTEN activity.

Authors:  Elahe Naderali; Amir Afshin Khaki; Jafar Soleymani Rad; Alireza Ali-Hemmati; Mohammad Rahmati; Hojjatollah Nozad Charoudeh
Journal:  Mol Biol Rep       Date:  2018-08-25       Impact factor: 2.316

9.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

10.  Sustained platelet-derived growth factor receptor alpha signaling in osteoblasts results in craniosynostosis by overactivating the phospholipase C-gamma pathway.

Authors:  Anne Moenning; Richard Jäger; Angela Egert; Wolfram Kress; Eva Wardelmann; Hubert Schorle
Journal:  Mol Cell Biol       Date:  2008-12-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.